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Abstract

Author Manuscript

The mu-opioid receptor 1 (OPRM1) binds endogenous opioids. Increasing evidence suggests that
endogenous OPRM1 agonists released at the time of trauma may contribute to the development of
post-traumatic musculoskeletal pain (MSP). In this prospective observational study we evaluated
the hypothesis that individuals with an AG or GG genotype at the OPRM1 A118G allele, which
results in a reduced response to opioids, would have less severe MSP six weeks after motor
vehicle collision (MVC). Based on previous evidence, we hypothesized that this effect would be
sex-dependent and most pronounced among women with substantial peritraumatic distress.
European American men and women ≥18 years of age presenting to the emergency department
after MVC and discharged to home after evaluation (n=948) were enrolled. Assessments included
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genotyping and six week evaluation of overall MSP severity (0–10 NRS). In linear regression
modeling a significant A118G allele × sex interaction was observed: an AG/GG genotype
predicted reduced MSP severity among women with substantial peritraumatic distress (β= −0.925,
p=0.014), but not among all women. In contrast, men with an AG/GG genotype experienced
increased MSP severity at six weeks (β=0.827, p=0.019). Further studies are needed to understand
biologic mechanisms mediating observed sex differences in A118G effects.
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More than 11 million Americans experience motor vehicle collision (MVC) each year; four
million of these individuals present to US emergency departments after the MVC for
evaluation.11 More than 90% of these individuals are discharged to home without fracture or
other identifiable injury,39 yet persistent musculoskeletal pain (MSP) in this population is a
common and costly public health problem.13 Mechanisms of chronic MSP development
remain poorly understood.

Author Manuscript

One mechanism which may contribute to the development of chronic MSP after MVC is
neuronal sensitization by endogenous opioids. Stressful events such as MVC have been
shown to trigger the release of endogenous opioids.26, 49 The binding of endogenous opioids
to μ-opioid receptors such as the mu-opioid receptor 1 (OPRM1) has been shown to produce
a bimodal response: initial analgesia followed by more persistent opioid-induced
hyperalgesia3, 14, 25, 26 (i.e., persistent OIH). The most common genetic variant in the
OPRM1 receptor is A118G;33 the presence of a G nucleotide at A118G has been shown to
result in reduced OPRM1 receptor binding affinity6, 42 and less OPRM1 receptor
expression.24 This results in less mRNA in response to OPRM1 binding in those with a G
allele, and a relative decrease in opioid effect.22, 29 Thus those with one or more copies of
the G allele at A118G would be expected to be protected from the downstream cellular
effects of endogenous opioids that result in persistent hyperalgesia after stress exposure.
Consistent with this hypothesis, a recent study found that women sexual assault survivors
with one or more copies of the G allele at A118G were found to have a reduced MSP burden
six weeks after sexual assault compared to those with an AA genotype.4

Author Manuscript

Currently, human data supporting the contribution of endogenous OIH to persistent pain
after stress exposure is limited to the single study of sexual assault survivors referenced
above. The findings have not been replicated, and, in addition, no studies have assessed for
evidence that the contribution of OIH to persistent pain outcomes is a more general
phenomena that may apply to other stress exposures aside from rape. In the present analysis
we used the A118G genetic variant to evaluate our primary hypothesis that OIH contributes
to persistent MSP after MVC. Because of substantial evidence that the effect of OIH is sexdependent (including those of A118G17, 36), and because the G allele was found to be
protective against persistent MSP among women sexual assault survivors, we hypothesized
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that the protective effect of one or more copies of the G allele would be greater in women. In
addition, because stress severity has been found to influence the magnitude of endogenous
opioid release,26, 37, 41, 46 we hypothesized that OIH (and therefore the protective effect of a
G allele at A118G) would be greater among women with substantial peritraumatic distress in
the early aftermath of MVC. (All women sexual assault survivors in the previous study
experienced substantial distress.4) Finally, because of evidence that clinical pain states may
result in OIH,2, 15, 43 in secondary analyses we evaluated for evidence of a greater protective
effect of A118G among individuals who reported high levels of pain prior to the MVC.

Methods
Study design and population

Author Manuscript

The details of the MVC study have been reported. In brief, individuals > 18 and ≤ 65 years
of age presenting to one of eight emergency departments in four no-fault insurance states
within 24 hours of MVC who did not have fracture or other injury requiring hospital
admission were enrolled. Patients who were not alert and oriented were excluded, as were
pregnant patients, prisoners, patients unable to read and understand English, patients taking
a β-adrenoreceptor antagonist, or patients taking opioids above a total daily dose of 30 mg of
oral morphine or equivalent. In addition, because genetic analyses are potentially biased by
population stratification,12 enrollment was also limited to non-Hispanic whites (the most
common ethnicity at study sites). Informed consent was obtained from all participants and
IRB approval was obtained at all study sites.
DNA collection and genotyping

Author Manuscript

Study personnel collected blood samples at the time of enrollment using PAXgene DNA
tubes. Following DNA purification (PAXgene blood DNA kit, QIAGEN, Valencia, CA,
USA), genotyping using the Sequenom platform (Sequenom, San Diego, CA, USA) was
performed at rs 1799971 (A118G). Two Hapmap samples and 2 repeat samples were
included in each genotyping batch (of 96 samples). Repeated genotyping demonstrated
>98% call agreement.
Assessments

Author Manuscript

Overall pain intensity in the emergency department and during the month prior to MVC
were assessed using verbal 0–10 numeric rating scales (NRSs). Verbal scores have
advantages in acute care settings, and verbally administered NRSs have been validated as a
substitute for Visual Analog Scales in the emergency department.7 Past pain scores were
calculated by summing the 0–10 pain severity scores from each of 20 body regions (scale of
0–200). Individuals reporting a score of 10 or more were defined as having high levels of
past pain. This cut-off of 10 was used because (1) this represents the top quartile of preMVC pain in this relatively young, healthy study cohort, (2) although the scale has a high
upper range, a score of 10 represents several regions of moderate or severe pain or a large
number of body regions with some pain. (Average overall pain intensity in the past week (0–
10 NRS) was evaluated six weeks after the MVC via web-based questionnaire or telephone
interview. Stress severity in the emergency department was measured using the
Peritraumatic Distress Inventory.9 The Peritraumatic Distress Inventory is a 13 item
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questionnaire assessing life threat, loss of control, helplessness/anger, and guilt/shame that
results in a score between 0–52. Individuals with a score of 23 or higher were considered to
have significant peritraumatic distress.35
Statistical Analysis

Author Manuscript

Sample sociodemographic characteristics were summarized using standard descriptive
statistics. Linear regression models were used to compare pain intensity levels six weeks
following MVC in individuals with AA vs GA/GG genotypes at OPRM1 polymorphism
rs1799971. To adjust for potential confounding factors, models were adjusted for age,
income, education, and emergency department study site by adding them as independent
variables to the model. Emergency department study site was added as a categorical variable
and thus resulted in eight distinct variables in the models. Because they are not of interest or
relevant to the study hypotheses other than as potential confounders, categorical variables
representing study site location are not shown in the tables. Additionally, to adjust for any
effect of A118G on pain prior to MVC or on acute pain, models were also adjusted for pain
at the time of initial evaluation and pain prior to MVC.
In addition to primary analyses, subgroup analyses were performed on subsets of individuals
with a) peritraumatic distress and b) high prior pain. Statistical significance of A118G effect
was determined via linear regression model t-statistic. Covariate-adjusted least-square
means and corresponding standard errors for pain scores according to A118G genotype were
also obtained from model outputs. All statistical analyses were completed using SPSS
software (v.21; SPSS Inc, Chicago, IL). P-values < 0.05 were considered statistically
significant.

Author Manuscript

Results
Study Enrollment, Follow-Up, and Genotyping
A total of 10,629 patients were screened, 1,416 were eligible, 969 consented to study
participation and 948 completed baseline evaluation. Six week follow-up assessments were
completed on 859/948 (91%) of enrolled patients. All study participants provided blood for
DNA genotyping; the genotyping call rate at A118G was >98% and the SNP was in HardyWeinberg equilibrium. Consistent with HapMap database and a previous large populationbased study,8 the prevalence of the G allele at A118G this European American sample was
~23% (214/948).
Characteristics of the Study Sample

Author Manuscript

Characteristics of the study sample are shown in Table 1. Most individuals had completed at
least some college, were married, worked full time, and had an annual income of $40,000 or
more. Fractures were present in 1/948 (<1%, phalanx fracture) participants, a small
laceration was present in 53/948 (6%) participants. The vast majority of study participants
had musculoskeletal strain only. More than one third of participants (355, 37%) reported
substantial peritraumatic distress in the emergency department, nearly three quarters of those
with peritraumatic distress (256, 72%) were female. There was no difference in
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peritraumatic distress symptom severity among individuals without and with one or more G
alleles (19.1 (9.9) vs. 19.2 (10.3), t = 0.140, p =0.886).
Evaluation for sex-dependent influence of A118G on 6 week MSP outcomes
We first evaluated whether the influence of A118G on six week MSP outcomes was sexdependent. As shown in Table 2, a significant allele-sex interaction was observed (β = 1.059,
p = 0.017). All remaining analyses were therefore stratified on patient sex.
Influence of A118G Genotype on 6 week MSP outcomes among all women and among
women with substantial peritraumatic distress

Author Manuscript

The influence of A118G on six week MSP outcomes among women study participants (n =
575) is shown in Table 3. Point estimates for overall MSP six weeks after MVC were lower
among women with one or more copies of the G allele at A118G (4.0 (3.5, 4.6) vs 4.3 (3.4,
4.7), p = 0.304), but no statistically significant difference was observed. When analyses
were limited to women with substantial peritraumatic distress (n = 256), the protective effect
of having one or more G alleles was more pronounced and statistically significant. Women
with peritraumatic distress and one or more copies of the G allele had lower overall MSP six
weeks after MVC than those with an AA genotype (3.6 (2.9, 4.8) vs 4.7 (4.1, 5.3), p = 0.014,
Figure 1).
Influence of A118G Genotype on 6 week MSP outcomes among all men and among men
with substantial peritraumatic distress

Author Manuscript

The influence of A118G on six week MSP outcomes among male study participants (n =
373) is shown in Table 3. In contrast to women, men with one or more copies of the G allele
at A118G had increased overall MSP six weeks after MVC (4.0 (3.3, 4.7) vs. 3.1 (2.7, 3.5),
p = 0.019). When analyses were limited to men with substantial peritraumatic distress (n =
99, Table 3), point estimates for overall MSP six weeks after MVC were higher among those
with one or more copies of the G allele than those with an AA genotype (4.5 (2.2, 6.7) vs.
4.1 (2.6, 5.6), p = 0.672, Figure 1), but no statistically significant difference was observed.
Secondary analyses evaluating A118G genotype influence on 6 week MSP outcomes
among individuals with a history of pre-MVC pain

Author Manuscript

Secondary analyses evaluated for the presence of OIH among individuals who reported the
greatest pain severity prior to MVC (average MSP severity during the month prior to MVC
in this top quartile was 22.5 (14.7)). Among women with the highest pain severity prior to
MVC (n = 97, Table 4a), mean overall MSP score six weeks after MVC was lower among
those with one or more copies of the G allele at A118G (2.4 (0.7, 4.1) vs 4.1 (2.9, 5.2); p =
0.028). Point estimates for mean MSP score six weeks after MVC were higher for men with
substantial pain prior to MVC (n = 50, Table 4a) and at least one G allele at A118G,
however this difference was not statistically significant (6.5 (4.4, 8.7) vs 5.4 (4.4, 6.4); p =
0.310, data not shown).
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Discussion
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To our knowledge, this is the first study evaluating the effect of a genetic variant influencing
opioid system function on persistent MSP symptoms after MVC. In a previous study of
European American women sexual assault survivors, all of whom had substantial
peritraumatic distress,4 those with a common genetic polymorphism in OPRM1 which
reduces the biological effect of receptor binding (one or more G alleles at A118G)
experienced less MSP in the first six weeks after assault.4 These results, together with
previous data demonstrating that (1) stress exposure results in the release of endogenous
opioids18, 26, 27, 43 and (2) stress-induced endogenous opioid release causes OIH26, 46,
support the hypothesis that endogenous OIH contributed to persistent MSP in the weeks
after assault. Results from the present study of MVC survivors provides further support for
the hypothesis that, among women trauma survivors experiencing substantial distress,
endogenous OIH might contribute to persistent MSP in the weeks after trauma. In addition,
these results suggest a specific mechanism by which an emotional response to a traumatic
event (distress) may contribute to a specific biologic mechanism (endogenous opioid
release) that increases MSP in the weeks after a trauma exposure. In the future, this
information may be useful in helping to tailor secondary preventive interventions (e.g., low
dose naloxone) for particular trauma survivor subgroups. The consistency of this finding
among women experiencing substantial distress after both sexual assault and MVC suggests
that this mechanism may contribute to MSP in the weeks after other trauma exposures as
well. However, future experiments will be necessary in order to fully substantiate this
possibility.

Author Manuscript
Author Manuscript

In contrast to the previous study of sexual assault survivors, in which all study participants
were women with substantial peritraumatic distress, the present MVC cohort study provided
the opportunity to evaluate the influence of A118G allele on MSP outcomes among men and
among both distressed and non-distressed women. The modest effect of A118G among all
women indicates that OIH has an effect on MSP symptoms in the weeks after trauma only
among women with substantial peritraumatic distress. While not significant, point estimates
in stratified analyses suggested that the effect of the G allele may be protective against pain
in women and may be associated with augmented pain in men. Of note, when peritraumatic
distress is added to the linear regression model for all individuals, a sex difference in the
effect of A118G is still observed. Point estimates for men vs women are consistent with
results from several previous studies. Fillingim et al found opposite effects of A118G on
experimental heat pain among men and women, with the presence of a G allele associated
with decreased pain in men and increased pain in women.17 Similarly, Olsen et al found
opposite effects on pain outcomes after low back surgery among men and women, with the
presence of a G allele associated with decreased pain in men and increased pain in women.36
In contrast to these studies, Lotsch et al found that healthy men and women volunteers with
one or more copies of the G allele at A118G experienced decreased cortical activation
following acute experimental pain stimuli28
Reasons for the varying direction of sex-dependent effects of A118G across studies remain
poorly understood. Regarding varied findings, one contributing factor is likely the varied
nature of the trauma/stress exposures and the timing of the outcome assessment across
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studies. Increasing evidence indicates that both the nature of the stress or pain exposure and
the timing of outcome assessments impact pain mechanisms.23, 30 Ethnic differences in
study populations also likely contribute to differences across study settings.5, 21

Author Manuscript

Within-study sex differences in the effect of A118G variants on pain outcomes are also
poorly understood, and may be due to fundamental sex differences in neural circuits in the
brain and spinal cord mediating stress-induced analgesia and opioid responses (reviewed
in32). For example, at equal levels of pain intensity, men and women have been shown to
differ in the magnitude and direction of response to μ-opioid system activation in distinct
brain nuclei,50 and female rats have been shown to exhibit more pronounced OIH in
response to morphine injection, which is thought to be mediated via melanocortin 1 receptor
versus NMDA type glutamate receptor involvement in females versus males,
respectively.10, 20, 34 The effect of opioid systems on other critical stress systems, which also
modulate neurosensory processing, such as the hypothalamic-pituitary-adrenal axis or
inflammatory factors, has also been shown to be sex-dependent.40, 47
Secondary analyses in the present study suggest that the protective effect of a G allele at
A118G was greater among those with the highest levels of pre-MVC pain. These results are
consistent with the findings of Rivat et al, who found that in rats that are pain experienced
stress induces hyperalgesia, not analgesia, through an NMDA-dependent pronociceptive
mechanism.43 Together these data suggest that prior life experiences play a substantial role
in shaping pain responses to stress, and that opioid systems may contribute to this
phenomenon.

Author Manuscript

As we have previously reported, we observed significant associations between baseline
income and education levels at the time of trauma and worse pain outcomes after MVC,31, 48
with lower income and education generally associated with worse pain outcomes. These
findings are consistent with those of other studies,1, 16 and demonstrate the influence of
sociodemographic characteristics on pain outcomes following trauma exposure.

Author Manuscript

Several limitations should be considered when interpreting our study results. First, some
women in the study sample received exogenous opioids, and this could have contributed to
our study results. However, when individuals who received opioids in the emergency
department (n = 284) and/or in the weeks after MVC (n = 168) were removed from analyses,
effect size differences for the presence of one or more copies of the G allele did not change
(data not shown). Similarly, in the previously reported sexual assault study, the effect of
A118G on pain outcomes did not change when women receiving exogenous opioids were
removed from analyses.4 Another limitation of our study is our small sample size and
evaluation of a single polymorphism. Previously, we showed association between FKBP5
and COMT genes with 6 week pain outcomes; when adding the tagging alleles from these
previous studies to the current models for A118G, the associations remain significant (data
not shown). In addition, we were also not able to assess the effects of ethnicity on our
findings since only European American individuals were enrolled in this study. Finally,
another limitation of this study is that, consistent with other studies enrolling trauma
survivors19, 44, 45 and the challenges of performing ethical studies of traumatized individuals
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in the acute aftermath of trauma, this study did not enroll all eligible study participants. The
generalizability of our results to those who declined enrollment is not known.

Acknowledgments
We would like to thank the participants for taking part in this study.
Funding: Research reported in this publication was supported by the National Institute of Arthritis and
Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR056328. The
content is solely the responsibility of the authors and does not necessarily represent the official views of the
National Institutes of Health.

References

Author Manuscript
Author Manuscript
Author Manuscript

1. Andersson HI, Ejlertsson G, Leden I, Rosenberg C. Chronic pain in a geographically defined
general population: studies of differences in age, gender, social class, and pain localization. The
Clinical journal of pain. 1993; 9:174–182. [PubMed: 8219517]
2. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology.
2006; 104:570–587. [PubMed: 16508405]
3. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist
remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003; 106:49–57. [PubMed:
14581110]
4. Ballina LE, Ulirsch JC, Soward AC, Rossi C, Rotolo S, Linnstaedt SD, Heafner T, Foley KA, Batts
J, Collette R, Holbrook D, Zelman S, McLean SA. mu-Opioid receptor gene A118G polymorphism
predicts pain recovery after sexual assault. The journal of pain: official journal of the American Pain
Society. 2013; 14:165–171. [PubMed: 23260451]
5. Belfer I, Young EE, Diatchenko L. Letting the Gene out of the Bottle: OPRM1 Interactions.
Anesthesiology. 2014
6. Beyer A, Koch T, Schroder H, Schulz S, Hollt V. Effect of the A118G polymorphism on binding
affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the
human mu-opioid receptor. Journal of neurochemistry. 2004; 89:553–560. [PubMed: 15086512]
7. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of
acute pain for use in the emergency department. Academic emergency medicine: official journal of
the Society for Academic Emergency Medicine. 2003; 10:390–392. [PubMed: 12670856]
8. Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H, McLean SA. mu-Opioid receptor
gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology. 2012;
116:896–902. [PubMed: 22433205]
9. Brunet A, Weiss DS, Metzler TJ, Best SR, Neylan TC, Rogers C, Fagan J, Marmar CR. The
Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. The American journal
of psychiatry. 2001; 158:1480–1485. [PubMed: 11532735]
10. Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ. NMDA receptor antagonism disrupts the
development of morphine analgesic tolerance in male, but not female C57BL/6J mice. American
journal of physiology. Regulatory, integrative and comparative physiology. 2006; 291:R315–326.
11. Bureau UC. Statistical abstract of the United States. Washington DC: US Census Bureau; 2012.
Available from: http://www.census.gov/compendia/statab/
12. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;
361:598–604. [PubMed: 12598158]
13. Carroll LJ, Holm LW, Hogg-Johnson S, Cote P, Cassidy JD, Haldeman S, Nordin M, Hurwitz EL,
Carragee EJ, van der Velde G, Peloso PM, Guzman J. Course and prognostic factors for neck pain
in whiplash-associated disorders (WAD): results of the Bone and Joint Decade 2000–2010 Task
Force on Neck Pain and Its Associated Disorders. Spine (Phila Pa 1976). 2008; 33:S83–92.
[PubMed: 18204405]

J Pain. Author manuscript; available in PMC 2016 July 01.

Linnstaedt et al.

Page 9

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

14. Celerier E, Gonzalez JR, Maldonado R, Cabanero D, Puig MM. Opioid-induced hyperalgesia in a
murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide
synthase. Anesthesiology. 2006; 104:546–555. [PubMed: 16508403]
15. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and
clinical considerations. The Clinical journal of pain. 2008; 24:479–496. [PubMed: 18574358]
16. Deyo RA, Tsui-Wu YJ. Functional disability due to back pain. A population-based study indicating
the importance of socioeconomic factors. Arthritis and rheumatism. 1987; 30:1247–1253.
[PubMed: 2961343]
17. Fillingim RB, Kaplan L, Staud R, Ness TJ, Glover TL, Campbell CM, Mogil JS, Wallace MR. The
A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated
with pressure pain sensitivity in humans. The journal of pain: official journal of the American Pain
Society. 2005; 6:159–167. [PubMed: 15772909]
18. Frew AK, Drummond PD. Negative affect, pain and sex: the role of endogenous opioids. Pain.
2007; 132(Suppl 1):S77–85. [PubMed: 17512663]
19. Hoge E, Worthington J, Nagurney J, Chang Y, Kay E, Feterowski C, Katzman A, Goetz J, Rosasco
M, Lasko N, Zusman R, Pollack M, Orr S, Pitman R. Effect of Acute Posttrauma Propranolol on
PTSD Outcome an Physiological Responses During Script-Driven Imagery. CNS Neurosci Ther.
2011:1–7. [PubMed: 21235731]
20. Holtman JR Jr, Wala EP. Characterization of morphine-induced hyperalgesia in male and female
rats. Pain. 2005; 114:62–70. [PubMed: 15733632]
21. Hwang IC, Park JY, Myung SK, Ahn HY, Fukuda KI, Liao Q. OPRM1 A118G Gene Variant and
Postoperative Opioid Requirement: A Systematic Review and Meta-analysis. Anesthesiology.
2014
22. Janicki PK, Schuler G, Francis D, Bohr A, Gordin V, Jarzembowski T, Ruiz-Velasco V, Mets B. A
genetic association study of the functional A118G polymorphism of the human mu-opioid receptor
gene in patients with acute and chronic pain. Anesthesia and analgesia. 2006; 103:1011–1017.
[PubMed: 17000822]
23. Kim SH, Stoicea N, Soghomonyan S, Bergese SD. Intraoperative use of remifentanil and opioid
induced hyperalgesia/acute opioid tolerance: systematic review. Frontiers in pharmacology. 2014;
5:108. [PubMed: 24847273]
24. Kroslak T, Laforge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ. The single nucleotide
polymorphism A118G alters functional properties of the human mu opioid receptor. Journal of
neurochemistry. 2007; 103:77–87. [PubMed: 17877633]
25. Laulin JP, Larcher A, Celerier E, Le Moal M, Simonnet G. Long-lasting increased pain sensitivity
in rat following exposure to heroin for the first time. The European journal of neuroscience. 1998;
10:782–785. [PubMed: 9749743]
26. Le Roy C, Laboureyras E, Gavello-Baudy S, Chateauraynaud J, Laulin JP, Simonnet G.
Endogenous opioids released during non-nociceptive environmental stress induce latent pain
sensitization Via a NMDA-dependent process. The journal of pain: official journal of the
American Pain Society. 2011; 12:1069–1079. [PubMed: 21723199]
27. Levine JD, Feldmesser M, Tecott L, Lane S, Gordon NC. The role of stimulus intensity and stress
in opioid-mediated analgesia. Brain research. 1984; 304:265–269. [PubMed: 6744043]
28. Lotsch J, Stuck B, Hummel T. The human mu-opioid receptor gene polymorphism 118A > G
decreases cortical activation in response to specific nociceptive stimulation. Behavioral
neuroscience. 2006; 120:1218–1224. [PubMed: 17201465]
29. Mague SD, Isiegas C, Huang P, Liu-Chen LY, Lerman C, Blendy JA. Mouse model of OPRM1
(A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proceedings of the
National Academy of Sciences of the United States of America. 2009; 106:10847–10852.
[PubMed: 19528658]
30. McLean SA. The scientific journey to predicting and preventing postoperative pain: recalling Dr.
Wall’s stories along the way. Anesthesiology. 2013; 119:1244–1246. [PubMed: 24343282]
31. McLean SA, Ulirsch JC, Slade GD, Soward AC, Swor RA, Peak DA, Jones JS, Rathlev NK, Lee
DC, Domeier RM, Hendry PL, Bortsov AV, Bair E. Incidence and predictors of neck and

J Pain. Author manuscript; available in PMC 2016 July 01.

Linnstaedt et al.

Page 10

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

widespread pain after motor vehicle collision among US litigants and nonlitigants. Pain. 2014;
155:309–321. [PubMed: 24145211]
32. Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial
phenomenon. Nature reviews. Neuroscience. 2012; 13:859–866.
33. Muralidharan A, Smith MT. Pain, analgesia and genetics. The Journal of pharmacy and
pharmacology. 2011; 63:1387–1400. [PubMed: 21988420]
34. Nemmani KV, Grisel JE, Stowe JR, Smith-Carliss R, Mogil JS. Modulation of morphine analgesia
by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism,
morphine dose, and time. Pain. 2004; 109:274–283. [PubMed: 15157688]
35. Nishi D, Matsuoka Y, Yonemoto N, Noguchi H, Kim Y, Kanba S. Peritraumatic Distress Inventory
as a predictor of post-traumatic stress disorder after a severe motor vehicle accident. Psychiatry
and clinical neurosciences. 2010; 64:149–156. [PubMed: 20447011]
36. Olsen MB, Jacobsen LM, Schistad EI, Pedersen LM, Rygh LJ, Roe C, Gjerstad J. Pain intensity
the first year after lumbar disc herniation is associated with the A118G polymorphism in the
opioid receptor mu 1 gene: evidence of a sex and genotype interaction. The Journal of
neuroscience: the official journal of the Society for Neuroscience. 2012; 32:9831–9834. [PubMed:
22815498]
37. Parikh D, Hamid A, Friedman TC, Nguyen K, Tseng A, Marquez P, Lutfy K. Stress-induced
analgesia and endogenous opioid peptides: the importance of stress duration. European journal of
pharmacology. 2011; 650:563–567. [PubMed: 21044625]
38. Platts-Mills TF, Ballina L, Bortsov AV, Soward A, Swor RA, Jones JS, Lee DC, Peak DA,
Domeier RM, Rathlev NK, Hendry PL, McLean SA. Using emergency department-based
inception cohorts to determine genetic characteristics associated with long term patient outcomes
after motor vehicle collision: methodology of the CRASH study. BMC Emerg Med. 2011; 11:14.
[PubMed: 21943293]
39. Platts-Mills TF, Hunold KM, Esserman DA, Sloane PD, McLean SA. Motor vehicle collisionrelated emergency department visits by older adults in the United States. Academic emergency
medicine: official journal of the Society for Academic Emergency Medicine. 2012; 19:821–827.
[PubMed: 22724382]
40. Prossin AR, Zalcman SS, Heitzeg MM, Koch AE, Campbell PL, Luan Phan K, Stohler CS, Zubieta
JK. Dynamic interactions between Plasma IL-1 Family Cytokines and Central Endogenous Opioid
Neurotransmitter Function in Humans. Neuropsychopharmacology: official publication of the
American College of Neuropsychopharmacology. 2014
41. Quintero L, Moreno M, Avila C, Arcaya J, Maixner W, Suarez-Roca H. Long-lasting delayed
hyperalgesia after subchronic swim stress. Pharmacology, biochemistry, and behavior. 2000;
67:449–458.
42. Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta
JK, Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with
brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of
Sciences of the United States of America. 2011; 108:9268–9273. [PubMed: 21576462]
43. Rivat C, Laboureyras E, Laulin JP, Le Roy C, Richebe P, Simonnet G. Non-nociceptive
environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats.
Neuropsychopharmacology: official publication of the American College of
Neuropsychopharmacology. 2007; 32:2217–2228. [PubMed: 17299508]
44. Roy-Byrne P, Russo J, Mcihelson E, Zatzick D, Pitman R, Berliner L. Risk Factors and Outcome
in Ambulatory Assault Victims Presenting to the Acute Emergency Department Setting:
Implications for Secondary Prevention Studies in PTSD. 2004:77–84.
45. Shalev AY, Freedman S, Peri T, Brandes D, Sahar T, Orr SP, Pitman RK. Prospective study of
posttraumatic stress disorder and depression following trauma. American Journal of Psychiatry.
1998; 155:630–637. [PubMed: 9585714]
46. Suarez-Roca H, Silva JA, Arcaya JL, Quintero L, Maixner W, Pinerua-Shuhaibar L. Role of muopioid and NMDA receptors in the development and maintenance of repeated swim stress-induced
thermal hyperalgesia. Behavioural brain research. 2006; 167:205–211. [PubMed: 16214233]

J Pain. Author manuscript; available in PMC 2016 July 01.

Linnstaedt et al.

Page 11

Author Manuscript

47. Uhart M, Chong RY, Oswald L, Lin PI, Wand GS. Gender differences in hypothalamic-pituitaryadrenal (HPA) axis reactivity. Psychoneuroendocrinology. 2006; 31:642–652. [PubMed:
16616815]
48. Ulirsch JC, Weaver MA, Bortsov AV, Soward AC, Swor RA, Peak DA, Jones JS, Rathlev NK,
Lee DC, Domeier RM, Hendry PL, McLean SA. No man is an island: living in a disadvantaged
neighborhood influences chronic pain development after motor vehicle collision. Pain. 2014;
155:2116–2123. [PubMed: 25107859]
49. Usdin, E.; K, R.; Axelrod, J. Stress, the role of catecholamines and other neurotransmitters;
Proceedings of the Third International Symposium on Catecholamines and Other
Neurotransmitters in Stress; New York, NY, Gordon and Breach Science Publishers, Smolenice
Castle, Czechoslovakia. 1984.
50. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA,
Stohler CS. mu-opioid receptor-mediated antinociceptive responses differ in men and women. The
Journal of neuroscience: the official journal of the Society for Neuroscience. 2002; 22:5100–5107.
[PubMed: 12077205]

Author Manuscript
Author Manuscript
Author Manuscript
J Pain. Author manuscript; available in PMC 2016 July 01.

Linnstaedt et al.

Page 12

Author Manuscript

Perspective
These results suggest a sex-dependent mechanism by which an emotional response to
trauma (distress) contributes to a biologic mechanism (endogenous opioid release) that
increases MSP in the weeks after stress exposure. These results also support the
hypothesis that endogenous opioids influence pain outcomes differently in men and
women.
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Highlights
-

We examined the effect of OPRM1 A118G on persistent pain following
MVC stress

-

Women with a G allele and distress at the time of MVC had reduced pain at 6
weeks

-

Men with a G allele had increased pain 6 weeks following MVC

-

Results show a sex dependent effect of A118G on pain development
following stress

-

Effect of OPRM1 allele on pain after stress suggests endogenous OIH
mechanism
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Figure 1.

Mean overall pain levels associated with AA versus AG/GG genotypes at OPRM1 allele
A118G 6 weeks after MVC in men and women with and without peritraumatic distress. Pain
levels were measured on a scale of 0–10 (NRS). Males = diamonds and females = circles. P
values were calculated via multivariate analyses adjusted for site, age, education, income,
pain prior to MVC and pain at the time of initial evaluation. Error bars represent the
standard error of the mean.
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Baseline characteristics of study participants
Characteristic

All (n=948)

Female (575, 61%)

Male (373, 39%)

Age (mean, SD)

35 (13)

35 (13)

35 (13)

Secondary school

283 (30)

150 (26)

133 (36)

Some college

312 (33)

172 (30)

140 (38)

College graduate/post-graduate

351 (37)

252 (44)

99 (27)

$0–$19,999

117 (12)

84 (16)

33 (10)

$20,000–$39,999

176 (19)

115 (22)

61 (19)

$40,000–$79,999

277 (29)

178 (35)

99 (30)

$80,000 or higher

273 (29)

139 (36)

131 (41)

Front end

439 (46)

262 (46)

177 (48)

Rear end

340 (36)

206 (36)

134 (36)

No serious relationship

297 (31)

178 (31)

119 (32)

In a serious relationship

267 (29)

171 (30)

96 (26)

Married

371 (39)

217 (38)

154 (42)

355 (37)

256 (47)

99 (28)

AA

732 (77)

442 (77)

290 (78)

AG

197 (21)

123 (21)

74 (20)

GG

17 (2)

9 (2)

8 (2)

Education (n, %)

Income (n, %)

Author Manuscript

Collision type (n, %)

Relationship (n, %)

Peritraumatic Distress (n, %)
Genotype (n, %)
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Linear regression model results demonstrating a main effect of OPMR1 allele A118G on overall pain severity
six weeks after motor vehicle collision (MVC) and an A118G-sex interaction (n = 859)
Independent variablea

Beta

SE

A118G (presence or absence of G allele)

0.815

0.358

0.023

Female Sex

0.857

0.222

<0.001

A118G allele * Sex

−1.059

0.446

0.017

Age

0.023

0.007

0.001

Education

−0.249

0.072

0.001

Income

−0.164

0.054

0.003

Pain at the time of initial evaluation

0.046

0.004

<0.001

Pain prior to MVC

0.025

0.041

0.549

P

Author Manuscript

a

Study site was also included in model as a categorical variable
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General linear models examining the relationship of OPRM1 allele A118G on overall pain severity six weeks
after motor vehicle collision (MVC) among all men and women and among men and women with substantial
peritraumatic distress after MVC
Independent variablea

Beta

SE

P

A118G allele

−0.264

0.268

0.324

Age

0.013

0.009

0.146

Education

−0.291

0.091

0.001

Income

−0.185

0.068

0.007

Pain at the time of initial evaluation

0.044

0.006

0.000

Pain prior to MVC

0.014

0.051

0.780

−0.925

0.375

0.014

Age

0.022

0.013

0.100

Education

−0.170

0.135

0.205

Income

−0.230

0.102

0.024

Pain at the time of initial evaluation

0.041

0.008

<0.001

Pain prior to MVC

0.035

0.070

0.621

A118G allele

0.827

0.352

0.019

Age

0.041

0.011

0.000

Education

−0.197

0.115

0.086

Income

−0.121

0.090

0.179

Pain at the time of initial evaluation

0.049

0.007

<0.001

Pain prior to MVC

0.066

0.070

0.347

A118G allele

0.340

0.802

0.672

Age

0.070

0.025

0.006

Education

0.115

0.242

0.636

Income

−0.255

0.169

0.132

Pain at the time of initial evaluation

0.039

0.010

<0.001

Pain prior to MVC

0.041

0.117

0.728

In all women (n = 575)

In women with peritraumatic distress (n = 256)

Author Manuscript

A118G allele

In men (n = 373)

Author Manuscript

In men with peritraumatic distress (n = 99)

a

Study site was also included in model as a categorical variable

Author Manuscript
J Pain. Author manuscript; available in PMC 2016 July 01.

Linnstaedt et al.

Page 18

Table 4

Author Manuscript

a. General linear model examining the relationship of OPRM1 allele A118G with overall pain intensity 6 weeks following MVC in
women reporting high levels of pain prior to MVC
Independent variablea

Beta

SE

P

A118G allele

−1.727

0.507

0.001

Age

0.017

0.017

0.309

Education

−0.182

0.168

0.276

Income

−0.565

−0.840

<0.001

Pain at the time of initial evaluation

0.226

0.093

0.015

In women with high pain prior to MVCb (n = 97)

b. Linear regression model examining the relationship of OPRM1 allele A118G with overall pain intensity 6 weeks following MVC in
men reporting high levels of pain prior to MVC

Author Manuscript

Independent variablea

Beta

SE

P

1.742

0.914

0.057

In men with high pain prior to MVCb (n = 50)
A118G allele
Age

0.065

0.031

0.034

Education

−0.530

−0..269

0.049

Income

0.100

0.224

0.656

Pain at the time of initial evaluation

0.646

0.133

<0.001

a

Study site was also included in model as a categorical variable

b

High pain prior to MVC was defined by a score of 10 or more (top quartile of individuals)
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